Citation Impact
Citing Papers
Drug Delivery with Carbon Nanotubes for In vivo Cancer Treatment
2008
Identification of interferon-stimulated genes that attenuate Ebola virus infection
2020 StandoutNobel
The DNA-damage response in human biology and disease
2009 StandoutNature
Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature
2008
Pancreatic cancer
2004 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Regulatory Mechanisms of Tumor Suppressor P16INK4Aand Their Relevance to Cancer
2011
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
2000 Standout
Senescence, apoptosis and therapy — cutting the lifelines of cancer
2003
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Genetic instabilities in human cancers
1998 StandoutNature
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
2020
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
2011 StandoutNature
The Hallmarks of Cancer
2000 Standout
p16INK4a expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation
2000
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
2001 StandoutNobel
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
A DNA damage checkpoint response in telomere-initiated senescence
2003 StandoutNature
Hypermethylation of tumor suppressor genes in cancer
1999
Pancreatic Adenocarcinoma
2014 Standout
Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas
2006
Pancreatic cancer
2002
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Apoptosis
2002 Standout
Molecular genetics of pancreatic intraepithelial neoplasia
2007
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
2008 Standout
Lipid‐based nanotherapeutics for siRNA delivery
2009
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion
2005
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
2010
Current advances in research and clinical applications of PLGA-based nanotechnology
2009
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Pancreatic Cancer
2010 Standout
Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas
1998
Rho and Rac Take Center Stage
2004 Standout
The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability
2001 StandoutNobel
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
The role of senescent cells in ageing
2014 StandoutNature
Abnormalities of the RB1 and DCC tumor suppressor genes: Uncommon in human pancreatic adenocarcinoma
1995
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms
2004
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
The cancer genome
2009 StandoutNature
Pancreatic cancer
2011 Standout
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
1994
Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy
2005
Current race in the development of DAAs (direct-acting antivirals) against HCV
2014
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
2012
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Autocrine Motility Factor Signaling Enhances Pancreatic Cancer Metastasis
2004
Pancreatic cancer–associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation
2013
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability.
2001
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
2006
Nonviral Vectors for Gene Delivery
2008 Standout
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Update on pancreatic intraepithelial neoplasia.
2008
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
2017
Nanoparticles in Photodynamic Therapy
2015 Standout
Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
2006
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
The retinoblastoma protein and cell cycle control
1995 Standout
Epigenetics and epigenetic alterations in pancreatic cancer.
2009
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Constitutive Expression of AID Leads to Tumorigenesis
2003 StandoutNobel
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Hypoxia Inducible Factor-1 Activation by Prolyl 4-Hydroxylase-2 Gene Silencing Attenuates Myocardial Ischemia Reperfusion Injury
2005
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment
2016
The Pathogenesis of Ebola Virus Disease
2016
The Human ARF Cell Cycle Regulatory Gene Promoter Is a CpG Island Which Can Be Silenced by DNA Methylation and Down-Regulated by Wild-Type p53
1998
Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.
1995
Pancreatic Cancer
2008
The Molecular Balancing Act of p16INK4a in Cancer and Aging
2013
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
1996 StandoutScience
Works of Steven E. Kern being referenced
Modeling Viral Kinetics and Treatment Outcome During Alisporivir Interferon-Free Treatment in Hepatitis C Virus Genotype 2 and 3 Patients
2013
Development of a sustained‐release system for perivascular delivery of dipyridamole
2005
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model
2004
Intracellular Kinetics of Non-Viral Gene Delivery Using Polyethylenimine Carriers
2007
Bidirectional on/off switch for controlled targeting of proteins to subcellular compartments
2004
Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment
2004
Long-circulating DNA-complexed biodegradable multiblock copolymers for gene delivery: degradation profiles and evidence of dysopsonization
2004
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.
1997
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19
2020
Allelotype of pancreatic adenocarcinoma.
1994
Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
2015
Hereditary pancreatic cancer
2011